Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element
- 1 August 2000
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (16) , 1421-1424
- https://doi.org/10.1038/sj.gt.3301262
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 24 references indexed in Scilit:
- Modified Human Immunodeficiency Virus-Based Lentiviral Vectors Display Decreased Sensitivity toTrans-Dominant RevHuman Gene Therapy, 2000
- Anti-HIV Effects of HIV VectorsVirology, 1998
- Mason–Pfizer Monkey Virus (MPMV) Constitutive Transport Element (CTE) Functions in a Position-Dependent MannerVirology, 1997
- A Structured Retroviral RNA Element That Mediates Nucleocytoplasmic Export of Intron-Containing RNAMolecular and Cellular Biology, 1997
- Development of HIV vectors for anti-HIV gene therapy.Proceedings of the National Academy of Sciences, 1996
- Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.Proceedings of the National Academy of Sciences, 1996
- A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread.Proceedings of the National Academy of Sciences, 1996
- Rev/RRE-Independent Mason–Pfizer Monkey Virus Constitutive Transport Element-Dependent Propagation of SIVmac239 Vectors Using a Single Round of Replication AssayVirology, 1996
- Analysis oftrans-Dominant Mutants of the HIV Type 1 Rev Protein for Their Ability to Inhibit Rev Function, HIV Type 1 Replication, and Their Use as Anti-HIV Gene TherapeuticsAIDS Research and Human Retroviruses, 1995
- Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev functionCell, 1989